Fig. 3From: Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival “early on” in neoadjuvant treatment of breast cancerKaplan-Meier recurrence-free survival estimates for METV at the early treatment time point (N = 142 cases) using as cut-points the lowest quartile (Q1, left), median quartile (Q2, middle), and highest quartile (Q3, right) with corresponding p-valuesBack to article page